ABBV-277
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-277, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants [Phase 1]